US FDA Reports Facial Paralysis In 4 Volunteers For Pfizer’s Covid-19 Vaccine

Mumbai : A new report by the United States Food and Drug Administration (FDA) regulators revealed that four volunteers for the COVID-19 experimental vaccine by Pfizer developed Bell’s Palsy after receiving vaccine shots, as per media reports.

Bell’s palsy is a condition that causes a temporary paralysis of the muscles in the face. It can occur when the nerve that controls your facial muscles becomes inflamed, swollen, or compressed.

FDA added in its report that it is unclear what caused Bell’s Palsy in the four volunteers. According to media reports, the FDA regulators have asked health experts to continuously monitor volunteers who had participated in the trials of the Covid-19 vaccine.

Earlier, Pfizer CEO Albert Bourla seemed dubious about the efficacy of the vaccine. During his interview with NBC’s Lestor Holt, he said, “I think this is something that needs to be examined. We are not certain about that right now with what we know.”

This comes as many countries, especially rich nations, are competing with each other to secure Covid-19 vaccines for their population. According to previous reports, some countries, including Canada, the US, UK, among others, have secured Covid-19 vaccines that are enough to inoculate their entire population multiple times, leaving lower-middle countries in a dearth of it.

  • Related Posts

    Telangana HM orders action against misleading pharma ads, sale of substandard drugs

    Hyderabad: In a stern message to the pharmaceutical industry, Telangana Health Minister Damodar Rajanarsimha has ordered the Drug Control Authority (DCA) to take stringent action against companies and individuals involved…

    LOC issued against man who sold fake Ozempic worth Rs 180 crore to US firm

    New Delhi:  A lookout circular (LOC) has been issued against the man who allegedly sold fake Ozempic worth Rs 180 crore to a United States-based firm, officers have said. According…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Telangana HM orders action against misleading pharma ads, sale of substandard drugs

    Telangana HM orders action against misleading pharma ads, sale of substandard drugs

    Aurobindo Pharma clarifies, reports of Zentiva buyout ‘premature’, no binding agreement yet

    Aurobindo Pharma clarifies, reports of Zentiva buyout ‘premature’, no binding agreement yet

    AIIMS study finds catheter infections in hospital widespread across India

    AIIMS study finds catheter infections in hospital widespread across India

    MNCs seek restart of refurbished medical device imports

    MNCs seek restart of refurbished medical device imports